What is Fuquan Capital Management, Inc. (FQCC)?

Fuquan Capital Management, Inc. (FQCC) is a stock in the Industrials sector, Industrial - Pollution & Treatment Controls industry. View full analysis on Stocks360.

What is the current price of FQCC?

The current price of FQCC is $0.00. Prices are updated in real time on Stocks360.

What is FQCC's price-to-earnings (PE) ratio?

FQCC's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is FQCC's market capitalization?

FQCC's market capitalization is $4.00, placing it in the small-cap tier.

Fuquan Capital Management, Inc. (FQCC)

Stock analysis · OTC · Industrials · Industrial - Pollution & Treatment Controls

$0.00

Market Cap

$4.00

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.00

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

200.00

Fuquan Capital Management, Inc. (FQCC) is a publicly traded company in the Industrials sector. Latest price: $0.00. Market cap $4.00. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $0.00 2026-10-29 · $0.00 (+0.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Fuquan Capital Management, Inc.

International Sustainability Group, Inc. (ISG), based in Malvern, Pennsylvania, is dedicated to developing and commercializing nutritional and various other products sourced from algae. The company's diverse range includes algae-based biomass for human, piscine, and animal diets, alongside algae cakes specifically formulated for livestock and aquaculture. ISG also manufactures astaxanthin, a compound utilized for alleviating joint discomfort and managing muscular degeneration, and omega-3, recognized for its efficacy in preventing heart conditions and cancer, as well as enhancing immune function. Beyond dietary applications, their portfolio encompasses algae oils for biofuel generation, bio-oil, and bio-plastic production, alongside solutions for carbon sequestration. Additionally, ISG offers nutraceuticals and natural remedies for disease prevention and treatment, notably spirulina, which serves as a crucial nutrient and protein supplement for human consumption and addressing malnutrition. The firm further provides sports medicine equipment engineered to boost mobility and balance, diminish joint pain, sculpt muscle, and aid in weight reduction. ISG serves clients across the nutr…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	0.00×
P/B	0.00×
P/FCF (TTM)	-0.00×
EV / EBITDA	-0.29×
EV / Sales	1.10×
Earnings Yield	-912244.26%
Free Cash Flow Yield	-16557475.00%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$98.91K
Revenue (TTM)	$90.00K
Net Income (TTM)	-$36.49K
Free Cash Flow (TTM)	-$658.60K
Net Debt	$98.91K
Working Capital	-$411.19K
Gross Margin	100.00%
Operating Margin	-384.80%
Net Margin	-388.91%
Return on Equity	-109.18%
Return on Invested Capital	-38.96%